Related Experiment Video
Updated: Feb 7, 2026

Manufacture of a Multi-Purpose Low-Cost Animal Bench-Model for Teaching Tracheostomy
Published on: May 18, 2019
Getting from the bench to the patient: biotechnology strategies
Hagop Youssoufian1, Jonathan Lewis
1One First Avenue, Parris Building 34, Navy Yard Plaza, Boston, MA 02129, USA.
Abstract:
Despite significant advances in understanding of molecular pathobiology, the adoption of this knowledge and its application to drug development is sporadic. Consequently, the drug development process has remained intrinsically laborious and inefficient. Translational research seeks to improve this process by integrating scientific advances into well-defined clinical challenges and opportunities. The focus of this article is on cancer therapeutics, specifically, 2 biotechnology organizations' advances in oncology: (1) optimizing the safety and efficacy of a novel DNA cross-linking small molecule, palifosfamide, and (2) bringing synthetic biology into clinical practice using a controllable gene therapy strategy with intratumorally injected interleukin-12 DNA, a potent cytokine.
Insights
This study explores cancer therapeutics, focusing on palifosfamide drug development and synthetic biology applications. It highlights advances in oncology drug discovery and gene therapy for improved patient outcomes.
Area of Science:
- Biotechnology
- Oncology
- Translational Research
Background:
- Drug development is inefficient despite molecular pathobiology advances.
- Translational research aims to bridge scientific discovery and clinical application.
- Cancer therapeutics face challenges in adopting new knowledge.
Purpose of the Study:
- To highlight advances in oncology drug development.
- To showcase the application of synthetic biology in cancer treatment.
- To discuss the optimization of novel cancer therapeutics.
Main Methods:
- Optimizing safety and efficacy of palifosfamide, a novel DNA cross-linking small molecule.
- Implementing synthetic biology for clinical practice via gene therapy.
- Utilizing intratumorally injected interleukin-12 DNA (a potent cytokine).
Main Results:
- Palifosfamide shows promise as a novel DNA cross-linking agent.
- Synthetic biology approaches are being integrated into clinical practice.
- Interleukin-12 DNA gene therapy demonstrates potential in oncology.
Conclusions:
- Biotechnology organizations are making significant strides in cancer therapeutics.
- Translational research is key to improving the efficiency of drug development.
- Novel approaches like gene therapy and optimized small molecules offer new hope for cancer treatment.
More Related Videos
Related Concept Videos
Strategies of Self-Presentation II: Self-Verification
Plant Breeding and Biotechnology
Persuasion Strategies
Coping Strategies: Problem Focused
For example, consider a student who struggles to understand their...
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Coping Strategies: Emotion Focused

